Healthcare Services

Immunogenomics Market Growth Prospects 2026–2030 with Innovation Trends and Competitive Landscape

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Immunogenomics Market Projected To Become By 2030 Based On Its 2026 Valuation?

The immunogenomics market has seen significant expansion in recent years. This market is projected to expand from $6.09 billion in 2025 to $7.07 billion in 2026, registering a compound annual growth rate (CAGR) of 16.1%. Historically, this growth can be ascribed to progress in genomic sequencing technologies, an increasing comprehension of immune-related genetic variations, the broadening scope of oncology and infectious disease research, augmented research funding, and the availability of high-throughput genomic tools.

The immunogenomics market size is anticipated to experience substantial growth in the forthcoming years. It is projected to expand to $12.73 billion by 2030, achieving a compound annual growth rate (CAGR) of 15.8%. This growth during the forecast period is attributable to the increasing demand for precision medicine solutions, the rising development of personalized vaccines and immunotherapies, the expansion of translational immunogenomics research, the growing integration of multi-omics data, and an increased adoption of cloud-based genomic analytics. Significant trends expected over the forecast period involve the increasing adoption of next-generation sequencing in immune profiling, the rising use of bioinformatics tools for immune data analysis, a growing focus on personalized immunotherapies, the expansion of genomic databases for immune research, and enhanced integration of AI in immunogenomic studies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28247&type=smp

What Drivers Are Shaping The Future Growth Of The Immunogenomics Market?

The rising incidence of infectious diseases is anticipated to fuel the expansion of the immunogenomics market in the future. These diseases are illnesses caused by detrimental microorganisms like bacteria, viruses, fungi, or parasites, which can transmit between individuals either directly or indirectly. The heightened occurrence of infectious diseases is attributed to increased global travel, which aids in the swift dissemination of pathogens across different regions. Immunogenomics improves the management of infectious diseases by allowing for precise examination of a host’s immune reactions and genetic predispositions. This reduces uncertainty in treatment by identifying patient-specific immune factors, thereby enhancing diagnostics, vaccine development, and customized therapeutic approaches. For instance, in February 2024, according to the UK Health Security Agency, a UK-based government agency, tuberculosis (a contagious bacterial infection that primarily affects the lungs) cases in England increased to 4,850 in 2023, marking a 10.7% rise from 4,380 cases in 2022. Consequently, the increasing prevalence of infectious diseases is a key factor propelling the growth of the immunogenomics market.

What Segment Groups Are Identified Within The Immunogenomics Market?

The immunogenomics market covered in this report is segmented –

1) By Product Type: Instruments, Consumables, Software, Services

2) By Technology: Next-Generation Sequencing, Microarray, Polymerase Chain Reaction, Other Technologies

3) By Application: Oncology, Infectious Diseases, Autoimmune Disorders, Transplantation, Other Applications

4) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Instruments: Sequencers, Microarray scanners, Flow cytometers

2) By Consumables: Reagents, Kits, Assay panels

3) By Software: Data analysis software, Bioinformatics tools, Visualization platforms

4) By Services: Sequencing services, Genomic profiling, Bioinformatics support

What Key Trends Are Influencing The Development Of The Immunogenomics Market?

Key players within the immunogenomics market are dedicating their efforts to crafting sophisticated solutions, such as a vaccine target prediction system. This system facilitates automated, comprehensive vaccine design and refines vaccine constructs by securing optimal antigen sequences. Functioning as a computational platform, the vaccine target prediction system utilizes bioinformatics algorithms alongside genomic and immunomic data to pinpoint prospective antigen molecules from pathogens or cancer cells. It then scrutinizes structural properties to prioritize and choose the most effective vaccine candidates with the greatest capacity to trigger protective immune responses. For example, in September 2024, Evaxion Biotech A/S, a Denmark-based biotechnology firm focused on artificial intelligence-driven immunotherapy and vaccine innovation, unveiled its clinically validated AI-Immunology platform. This represents an advanced EDEN artificial intelligence prediction model that incorporates a novel toxin antigen predictor, thereby enhancing the accuracy and dependability of bacterial toxin antigen identification for the development of next-generation bacterial vaccines. Moreover, the platform emulates the immune system to engineer personalized and future-generation immunotherapies, having shown robust connections between its artificial intelligence-derived predictions and clinical results.

Which Companies Hold Significant Positions In The Immunogenomics Market?

Major companies operating in the immunogenomics market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Illumina Inc., BGI Group, GenScript Biotech Corporation, CareDx Inc., Oxford Nanopore Technologies plc, Genewiz LLC, Adaptive Biotechnologies Corporation, GenomOncology LLC, Personalis Inc., Variantyx Inc., CD Genomics Inc., Sengenics Corporation, GeneCentric Therapeutics Inc., Immunogenomics Inc., ImmuQuad Biotechnologies Inc., Neomics Pharmaceuticals LLC, Yemaachi Biotech Ltd., BioAnalytica Biotechnology Systems Inc.

Read the full immunogenomics market report here:

https://www.thebusinessresearchcompany.com/report/immunogenomics-global-market-report

Which Geographic Regions Are Influencing Demand In The Immunogenomics Market?

North America was the largest region in the immunogenomics market in 2025. The regions covered in the immunogenomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Immunogenomics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28247&type=smp

Browse Through More Reports Similar to the Global Immunogenomics Market 2026, By The Business Research Company

Immunoassay Global Market Report

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Automated Immunoassay Analyzers Global Market Report

https://www.thebusinessresearchcompany.com/report/automated-immunoassay-analyzers-global-market-report

Immunomodulator Global Market Report

https://www.thebusinessresearchcompany.com/report/immunomodulator-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795